Pediatric Human Metapneumovirus Follow-up

Updated: May 02, 2018
  • Author: Joseph Domachowske, MD; Chief Editor: Russell W Steele, MD  more...
  • Print
Follow-up

Deterrence/Prevention

See the list below:

  • Until more information becomes available, using contact precautions in all hospitalized patients with bronchiolitis is prudent, whether or not human respiratory syncytial virus (RSV) is present. Guidelines are available for the diagnosis and treatment of bronchiolitis in children. [17]

  • Development of anti–human metapneumovirus (hMPV) monoclonal antibodies continues. In the future, such preparations may become available for the passive prevention of human metapneumovirus infection in high-risk infants.

Next:

Complications

See the list below:

  • Respiratory failure may develop.

Previous
Next:

Prognosis

See the list below:

  • Prognosis appears excellent, but further information is needed.

Previous